In HFpEF, the benefit of empagliflozin on a composite of CV death or HF hospitalization at 26 mo did not vary by diabetes status.
Publication
, Journal Article
Fudim, M; Van Spall, HGC
Published in: Ann Intern Med
October 2022
Filippatos G, Butler J, Farmakis D, et al. Empagliflozin for heart failure with preserved left ventricular ejection fraction with and without diabetes. Circulation. 2022;146:676-86. 35762322.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Ann Intern Med
DOI
EISSN
1539-3704
Publication Date
October 2022
Volume
175
Issue
10
Start / End Page
JC111
Location
United States
Related Subject Headings
- Ventricular Function, Left
- Stroke Volume
- Humans
- Hospitalization
- Heart Failure
- Glucosides
- General & Internal Medicine
- Diabetes Mellitus
- Benzhydryl Compounds
- 3202 Clinical sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Fudim, M., & Van Spall, H. G. C. (2022). In HFpEF, the benefit of empagliflozin on a composite of CV death or HF hospitalization at 26 mo did not vary by diabetes status. Ann Intern Med, 175(10), JC111. https://doi.org/10.7326/J22-0075
Fudim, Marat, and Harriette G. C. Van Spall. “In HFpEF, the benefit of empagliflozin on a composite of CV death or HF hospitalization at 26 mo did not vary by diabetes status.” Ann Intern Med 175, no. 10 (October 2022): JC111. https://doi.org/10.7326/J22-0075.
Fudim M, Van Spall HGC. In HFpEF, the benefit of empagliflozin on a composite of CV death or HF hospitalization at 26 mo did not vary by diabetes status. Ann Intern Med. 2022 Oct;175(10):JC111.
Fudim, Marat, and Harriette G. C. Van Spall. “In HFpEF, the benefit of empagliflozin on a composite of CV death or HF hospitalization at 26 mo did not vary by diabetes status.” Ann Intern Med, vol. 175, no. 10, Oct. 2022, p. JC111. Pubmed, doi:10.7326/J22-0075.
Fudim M, Van Spall HGC. In HFpEF, the benefit of empagliflozin on a composite of CV death or HF hospitalization at 26 mo did not vary by diabetes status. Ann Intern Med. 2022 Oct;175(10):JC111.
Published In
Ann Intern Med
DOI
EISSN
1539-3704
Publication Date
October 2022
Volume
175
Issue
10
Start / End Page
JC111
Location
United States
Related Subject Headings
- Ventricular Function, Left
- Stroke Volume
- Humans
- Hospitalization
- Heart Failure
- Glucosides
- General & Internal Medicine
- Diabetes Mellitus
- Benzhydryl Compounds
- 3202 Clinical sciences